Breaking News Instant updates and real-time market news.

COST

Costco

$167.07

1.86 (1.13%)

, ALB

Albemarle

$135.31

-4.35 (-3.11%)

12:17
10/06/17
10/06
12:17
10/06/17
12:17

On The Fly: Top stock stories at midday

Stocks opened lower and have remained in negative territory, though the losses have been mild. The weakness is understandable as the market may be tried after logging six consecutive closing highs and given the weak jobs report, though that is being largely written off as a function of the impact of the two major hurricanes during the month. Oil prices are especially weak, falling roughly 3% today after prices just recently hit a five-month high. ECONOMIC EVENTS: In the U.S., analysts had been expecting job growth to slump in September due to Hurricanes Harvey and Irma, but still predicted a net addition of jobs. However, the economy lost 33,000 jobs last month, marking the first decline since September 2010. The unemployment rate declined slightly to 4.2% and average hourly wages rose 2.9% from a year ago. Wholesale sales jumped 1.7% in August with inventories up 0.9%. COMPANY NEWS: Shares of Costco (COST) have slid nearly 6% and the stock was downgraded to Equal Weight from Overweight at Morgan Stanley despite the company's report last night of better than expected Q4 earnings. Analyst Simeon Gutman, who penned the downgrade, and his peer at Deutsche Bank, Paul Trussell, both voiced concerns about its membership growth. MAJOR MOVERS: Among the notable gainers was Synchronoss (SNCR), which jumped 32% after entering into an exclusivity agreement with Siris Capital to allow for negotiation of definitive agreements, including a potential sale of the company's Intralinks unit. Also higher was Ferroglobe (GSM), which is up about 10% after Oppenheimer analyst Ian Zaffino said he views the Department of Commerce's preliminary silicon metal anti-dumping ruling as highly favorable for the company. Albemarle (ALB) was among the noteworthy losers, dropping 3% after Goldman Sachs analyst Robert Koort downgraded the stock to Neutral and removed the shares from his firm's Conviction Buy list. Koort says the stock has transformed from a value-oriented chemical stock into a "thematic growth engine" as investors shifted their focus to the potential of an electric vehicle revolution. Also lower was Darling Ingredients (DAR), which fell 9% after JPMorgan analyst Thomas Palmer downgraded the stock to Neutral citing valuation as well as regulatory risk. INDEXES: Near midday, the Dow was down 33.57, or 0.15%, to 22,741.82, the Nasdaq was down 8.45, or 0.13%, to 6,576.91, and the S&P 500 was down 7.60, or 0.3%, to 2,544.47.

COST

Costco

$167.07

1.86 (1.13%)

ALB

Albemarle

$135.31

-4.35 (-3.11%)

DAR

Darling Ingredients

$16.28

-1.61 (-9.00%)

SNCR

Synchronoss

$10.72

-0.01 (-0.09%)

GSM

Ferroglobe

$13.52

-0.01 (-0.07%)

  • 17

    Oct

  • 19

    Oct

  • 09

    Nov

  • 14

    Nov

  • 15

    Nov

COST Costco
$167.07

1.86 (1.13%)

10/06/17
MSCO
10/06/17
DOWNGRADE
MSCO
Equal Weight
Costco downgraded to Equal Weight from Overweight at Morgan Stanley
10/06/17
RBCM
10/06/17
NO CHANGE
Target $190
RBCM
Outperform
Costco has some of the best traffic growth in retail, says RBC Capital
RBC Capital analyst Scot Ciccarelli said Costco reported better than expected Q4 results as total comps increased 5.7% versus his 5.3% estimate and consensus of 5.1%, while gross margin pressures were largely offset by expense leverage. Despite investors fears regarding risk from e-commerce, the analyst said Costco continues to have some of the best traffic growth in retail and is gaining traction from its own e-commerce initiates. Ciccarelli said he remains a buyer of Costo and increased his price target on shares to $190 from $184 and reiterated his Outperform rating on shares.
10/06/17
BARD
10/06/17
NO CHANGE
Target $200
BARD
Outperform
Any post-earnings pullback in Costco provides a buying opportunity, says Baird
Baird analyst Peter Benedict noted Costco reported better than expected Q4 earnings and said it remains a compelling growth staple idea with its healthy fundamentals and an improved valuation profile. The analyst said any pullback in Costco share would be a good buying opportunity and shares look attractive at current levels. Benedict reiterated his Outperform rating and $200 price target on Costco shares.
10/06/17
10/06/17
DOWNGRADE
Target $165

Equal Weight
Costco downgraded on EPS growth slowdown at Morgan Stanley
As previously reported, Morgan Stanley analyst Simeon Gutman downgraded Costco to Equal Weight from Overweight, stating that after its Q4 report last night he has cut his FY18 EPS growth estimate to $6.30. Moderating membership growth also led him to lower his EBITDA multiples, said Gutman, who added that the combination of decelerating EPS growth and "membership slippage" may make it tough for the stock to outperform. Gutman lowered his price target to $165 from $190 on Costco shares, which are down 4.5% to $159.50 in pre-market trading following last night's quarterly report.
ALB Albemarle
$135.31

-4.35 (-3.11%)

10/06/17
GSCO
10/06/17
DOWNGRADE
GSCO
Neutral
Albemarle downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Robert Koort downgraded Albemarle to Neutral and removed the shares from his firm's Conviction Buy list. The company over the past two years has transformed from a value-oriented chemical stock into a "thematic growth engine" as investors shifted their focus to the potential of an electric vehicle revolution, Koort tells investors in a research note. The analyst believes the upside is priced in with the stock close to his unchanged price target for $142. He believes, however, that the lithium market will remain tight through the end of the decade. Albemarle closed yesterday up $1.44 to $139.66.
09/29/17
LOOP
09/29/17
INITIATION
LOOP
Buy
Albemarle initiated at Loop Capital
As noted earlier, Loop Capital started coverage of Albemarle with a $150 price target and a Buy rating. Analyst Chris Kapsch calls the company " arguably the best organic growth story across the chemicals/materials space" and a "must-own " stock. The analyst expects the stock to rise further, given the rapid expected growth of the electric car market.
09/28/17
LOOP
09/28/17
INITIATION
LOOP
Buy
Albemarle initiated with a Buy at Loop Capital
Loop Capital analyst Chris Kapsch initiated Albemarle with a Buy rating and $150 price target.
10/06/17
10/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Spirit Airlines (SAVE) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying the company's revenue outlook "may face greater downside risk" than peers given the competitive intensity of its markets. 2. Albemarle (ALB) downgraded to Neutral from Conviction Buy at Goldman Sachs with analyst Robert Koort saying the company over the past two years has transformed from a value-oriented chemical stock into a "thematic growth engine" as investors shifted their focus to the potential of an electric vehicle revolution. 3. Cree (CREE) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 4. Valero (VLO) downgraded to Neutral from Overweight at JPMorgan with Phil Gresh citing valuation following the recent rally. 5. Walgreens Boots Alliance (WBA) downgraded to Equal Weight at Morgan Stanley with analyst Ricky Goldwasser saying he expects the company's guidance to come in below consensus estimates when it is provided later this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DAR Darling Ingredients
$16.28

-1.61 (-9.00%)

03/22/17
BARD
03/22/17
INITIATION
Target $19
BARD
Outperform
Darling Ingredients initiated with an Outperform at Baird
Baird analyst Ben Kallo initiated Darling with an Outperform and a $19 price target.
08/14/17
JPMS
08/14/17
NO CHANGE
Target $19
JPMS
Overweight
Darling Ingredients price target raised to $19 from $17 at JPMorgan
JPMorgan analyst Thomas Palmer raised his price target for Darling Ingredients to $19 following last week's Q2 results. The company's Diamond Green Diesel joint venture is beginning to demonstrate the long-term earnings ramp management has long spoke about, Palmer tells investors in a research note. The analyst reiterates an Overweight rating on the shares.
09/26/17
BARD
09/26/17
NO CHANGE
Target $20
BARD
Outperform
Darling Ingredients remains a top pick, says Baird
Baird analyst Ben Kallo said key drivers are in place to support substantial EBITDA growth in 2018 and beyond for Darling Ingredients. The analyst also cited key regulatory drivers as well and said others could fall into place, which will boost the company's growth profile. Kallo reiterated his Outperform rating and $20 price target on Darling Ingredients and said it remains a top pick.
10/06/17
JPMS
10/06/17
DOWNGRADE
Target $18
JPMS
Neutral
Darling Ingredients downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Thomas Palmer downgraded Darling Ingredients to Neutral citing valuation with the shares up 39% year-to-date as well as regulatory risk. The U.S. Commerce Department's preliminary duties on biodiesel imports from Argentina and Indonesia were greater than anticipated and the EPA's decision to potentially reduce biomass-based diesel mandates for 2018 and 2019 could also weigh on pricing, Palmer tells investors in a research note. The analyst lowered his price atrget for the shares to $18 from $19.
SNCR Synchronoss
$10.72

-0.01 (-0.09%)

09/19/17
RAJA
09/19/17
DOWNGRADE
RAJA
Underperform
Synchronoss downgraded to Underperform from Outperform at Raymond James
Raymond James analyst Tavis McCourt downgraded Synchronoss (SNCR) two notches to Underperform from Outperform following news Siris Capital is no longer interested in an all-cash transaction for all the outstanding shares of the company and has withdrawn its $18 per share bid from June 22. Further, the analyst believes it increasingly unlikely that the current strategic review will result in an acquisition at a premium and expects share to come under pressure and stay in the range prior to the Siris indication of interest.
09/20/17
DBAB
09/20/17
NO CHANGE
Target $10
DBAB
Hold
Synchronoss price target lowered to $10 from $18 at Deutsche Bank
Deutsche Bank analyst Nandan Amladi cut his price target for Synchronoss Technologies to $10 citing increased uncertainty after Siris Capital decided not to pursue an all-cash acquisition of the company. Yesterday's 40% selloff retraces the pre-offer levels in June, Amladi tells investors in a research note. He continues to believe an eventual transaction "provides a clean exit" for Synchronoss shareholders, given the "mounting complications" facing the company. The analyst keeps a Hold rating on the shares.
09/19/17
09/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Market Perform at Wells Fargo with Wells Fargo with analyst Tom Nikic saying with consumers having filled their closets with athletic wear over the past seven years, the category "appears poised to take a breather for now." The analyst cut his price target for the shares to $13 from $17. 2. Kellogg (K) downgraded to Neutral from Overweight at Piper Jaffray with analyst Michael Lavery saying cereal could be at risk from shrinking center store space. 3. Nike (NKE) downgraded to Neutral from Positive at Susquehanna saying that his checks indicate that the North American and European businesses are decelerating as some key categories, especially basketball, have underperformed, resulting in excess inventory that will pressure sales and margins. 4. Synchronoss (SNCR) downgraded to Underperform from Outperform at Raymond James with analyst Tavis McCourt citing the news that Siris Capital is no longer interested in an all-cash transaction for all the outstanding shares of the company and has withdrawn its $18 per share bid from June 22. Further, the analyst believes it increasingly unlikely that the current strategic review will result in an acquisition at a premium and expects share to come under pressure and stay in the range prior to the Siris indication of interest. 5. Sony (SNE) downgraded to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/17
JPMS
06/22/17
NO CHANGE
JPMS
Neutral
Synchronoss comments on carriers should help ease concerns, says JPMorgan
JPMorgan analyst Sterling Auty said that comments made by Synchronoss (SNCR) in a presentation to its lenders regarding AT&T (T) and Verizon (VZ) continuing to be cloud customers should help ease some of the concern investors have had around the company's cloud business. Auty keeps a Neutral rating on Synchronoss shares.
GSM Ferroglobe
$13.52

-0.01 (-0.07%)

11/15/16
JPMS
11/15/16
DOWNGRADE
Target $10
JPMS
Neutral
Ferroglobe downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Michael Gambardella downgraded Ferroglobe to Neutral saying the company's volumes for silicon metals, silicon alloys, and manganese alloys have all been sliding lower throughout the year. The analyst lowered his price target for the shares to $10 from $12.
10/06/17
OPCO
10/06/17
NO CHANGE
Target $18
OPCO
Outperform
Anti-dumping ruling highly favorable for Ferroglobe, says Oppenheimer
Oppenheimer analyst Ian Zaffino views the Department of Commerce's preliminary anti-dumping duties against Australia, Brazil and Norway for silicon metal as highly favorable for Ferroglobe. The largest importer of silicon metal, Brazi, was hit with the highest rate of 56.78%-134.92%, the analyst notes. The duties should put "meaningful upward pressure" on silicon metal prices, which currently stand at $1.24 versus $1.46 in January 2015, Zaffino tells investors in a research note. He reminds investors that 10c per pound move in silicon metal represents an incremental $70M in EBITDA for Ferroglobe. The analyst maintains an Outperform rating on the shares with an $18 price target.
08/18/17
JEFF
08/18/17
NO CHANGE
Target $17
JEFF
Buy
Ferroglobe price target raised to $17 from $12 at Jefferies
Jefferies analyst Martin Englert raised his price target for Ferroglobe to $17 and reiterates a Buy rating on the shares. There is a "confluence of positive indicators pointing to a possible perfect storm" driving silicon metal prices incrementally higher, Englert tells investors in a research note. The analyst raised his EBITDA estimates for Ferroglobe by 40% for 2017-2018, largely on higher pricing.
03/13/17
RILY
03/13/17
INITIATION
Target $14.25
RILY
Buy
Ferroglobe resumed with a Buy at B. Riley
B. Riley analyst Ian Corydon resumed coverage of Ferroglobe with a Buy rating and $14.25 price target.

TODAY'S FREE FLY STORIES

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPCI

Intellipharmaceutics

17:23
10/20/17
10/20
17:23
10/20/17
17:23
Hot Stocks
Breaking Hot Stocks news story on Intellipharmaceutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:21
10/20/17
10/20
17:21
10/20/17
17:21
Hot Stocks
DBV Technologies: PEPITES trial does not reach primary endpoint »

DBV Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.92

1.17 (2.18%)

17:08
10/20/17
10/20
17:08
10/20/17
17:08
Periodicals
Regulator criticizes Wells Fargo over deceptive auto insurance program, NYT says »

The Office of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

  • 07

    Nov

  • 29

    Nov

  • 15

    Jan

ALIM

Alimera Sciences

17:01
10/20/17
10/20
17:01
10/20/17
17:01
Syndicate
Alimera Sciences to sell $25M in shares in an 'at the market offering' »

On October 20, Alimera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$32.66

0.33 (1.02%)

16:51
10/20/17
10/20
16:51
10/20/17
16:51
Syndicate
Breaking Syndicate news story on Symantec »

Symantec files to sell 1M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

EBMT

Eagle Bancorp

$19.55

0.15 (0.77%)

16:44
10/20/17
10/20
16:44
10/20/17
16:44
Hot Stocks
Breaking Hot Stocks news story on Eagle Bancorp »

EJF Capital reports 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$11.26

1.99 (21.47%)

16:43
10/20/17
10/20
16:43
10/20/17
16:43
Hot Stocks
Breaking Hot Stocks news story on KalVista »

Longwood Fund II reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.19

0.002 (1.08%)

16:41
10/20/17
10/20
16:41
10/20/17
16:41
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$345.10

-6.71 (-1.91%)

16:40
10/20/17
10/20
16:40
10/20/17
16:40
Hot Stocks
Tesla amends 'warehouse agreements' to increase commitments to $1.1B »

On October 18,Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

SNV

Synovus

$47.30

0.54 (1.15%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Hot Stocks
Synovus CBO sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 15

    Nov

GTXI

GTx

$7.92

0.1 (1.28%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Syndicate
Breaking Syndicate news story on GTx »

GTx files to sell 8.77M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

, BKMU

BankMutual

$10.80

0.55 (5.37%)

16:36
10/20/17
10/20
16:36
10/20/17
16:36
Conference/Events
BankMutual to host special shareholder meeting »

Special Shareholder…

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

BKMU

BankMutual

$10.80

0.55 (5.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CNXR

Connecture

$0.49

-0.01 (-2.00%)

16:35
10/20/17
10/20
16:35
10/20/17
16:35
Hot Stocks
Breaking Hot Stocks news story on Connecture »

Connecture trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$23.83

0.25 (1.06%)

, PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

16:31
10/20/17
10/20
16:31
10/20/17
16:31
General news
On The Fly: Top stock stories for Friday »

Stocks opened sharply…

GE

General Electric

$23.83

0.25 (1.06%)

PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

CELG

Celgene

$121.33

-14.63 (-10.76%)

SNCR

Synchronoss

$11.39

-0.12 (-1.04%)

IL

Bought by SNCR

SKX

Skechers

$33.99

9.96 (41.45%)

PYPL

PayPal

$70.97

3.72 (5.53%)

NCR

NCR Corp.

$33.05

-4 (-10.80%)

LHO

LaSalle Hotel

$28.52

-1.94 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 29

    Nov

  • 30

    Nov

16:30
10/20/17
10/20
16:30
10/20/17
16:30
Options
Preliminary option volume of 22.9M today »

Preliminary option volume…

MKL

Markel

$1,078.23

14.88 (1.40%)

, SNC

State National

$21.05

0.02 (0.10%)

16:26
10/20/17
10/20
16:26
10/20/17
16:26
Conference/Events
State National to host special shareholder meeting »

Special Shareholder…

MKL

Markel

$1,078.23

14.88 (1.40%)

SNC

State National

$21.05

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

RYTM

Rhythm Pharmaceuticals

$23.08

-0.17 (-0.73%)

16:22
10/20/17
10/20
16:22
10/20/17
16:22
Hot Stocks
Breaking Hot Stocks news story on Rhythm Pharmaceuticals »

Orbimed Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.